Benzinga's Volume Movers
Verint Systems (NASDAQ: VRNT) shares rose 3.88% to $48.75. The volume of Verint Systems shares traded was 881% higher than normal. Verint reported better-than-expected fourth-quarter results and issued a strong full-year forecast. Verint reported its adjusted earnings of $0.91 per share on revenue of $257.1 million.
Durata Therapeutics (NASDAQ: DRTX) shares climbed 5.30% to $14.18. The volume of Durata Therapeutics shares traded was 861% higher than normal. The FDA Advisory Committee unanimously recommended the approval of Durata's Dalvance.
Intuitive Surgical (NASDAQ: ISRG) shares moved up 10.89% to $485.70. The volume of Intuitive Surgical shares traded was 617% higher than normal. Intuitive Surgical announced the FDA clearance and U.S. introduction of the new da Vinci Xi Surgical System.
Balchem (NASDAQ: BCPC) surged 13.56% to $59.19. The volume of Balchem shares traded 499% higher than normal. Balchem announced its plans to aquire SensoryEffects for $567 million.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.